T025
Product Specifications
CAS Number
2407433-00-3
Target
CDK
Applications
Cell Cycle
Molecular Formula
C21H18N8
Additionnal Information
T025 is as an orally available and potent inhibitor of Cdc2‐like kinases (CLKs) with an IC50s of 0.93 nM, 1 nM, 14 nM, 1.5 nM for CLK1, CLK2, CLK3, DYRK1B respectively. It exhibits anti‐tumor efficacy and can be used in MYC‐driven cancer research.
More Discoveries
Explore Other Products
Browse additional items from our catalog
ARP5450-01 10 µg
Recombinant Human Leukocyte Ig-Like Receptor A2/LILRA2/ILT1/CD85h Protein (C-6His)
Sign In for Pricing
View Details 
ARP5450-02 50 µg
Recombinant Human Leukocyte Ig-Like Receptor A2/LILRA2/ILT1/CD85h Protein (C-6His)
Sign In for Pricing
View Details ARP5450-03 100 µg
Recombinant Human Leukocyte Ig-Like Receptor A2/LILRA2/ILT1/CD85h Protein (C-6His)
Sign In for Pricing
View Details 
ARP5450-04 1 mg
Recombinant Human Leukocyte Ig-Like Receptor A2/LILRA2/ILT1/CD85h Protein (C-6His)
Sign In for Pricing
View Details